Recent advances in immunotherapy and targeted therapies offer new hope for treating cancers associated with microorganisms. For instance, checkpoint inhibitors have shown promise in treating virus-associated cancers like HPV-related cervical cancer and EBV-related lymphomas. Research is ongoing to develop more specific treatments that target the underlying microbial causes of cancer.
